<SEC-DOCUMENT>0001144204-16-101657.txt : 20160513
<SEC-HEADER>0001144204-16-101657.hdr.sgml : 20160513
<ACCEPTANCE-DATETIME>20160513135553
ACCESSION NUMBER:		0001144204-16-101657
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20160509
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160513
DATE AS OF CHANGE:		20160513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		161647477

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v439909_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
May 9, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">BIOANALYTICAL SYSTEMS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Indiana</FONT></TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0-23357 </FONT></TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 29%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">35-1345024</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2701 KENT AVENUE</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WEST LAFAYETTE, INDIANA</P></TD>
    <TD STYLE="width: 11%">&nbsp;</TD>
    <TD STYLE="width: 42%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">47906-1382</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Registrant's telephone number, including
area code: (765) 463-4527</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  <FONT STYLE="font-family: Wingdings">&#168;</FONT>&nbsp;&nbsp;&nbsp;Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule
14a-12 under the Exchange Act(17CFR240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  <FONT STYLE="font-family: Wingdings">&#168;</FONT>&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act(17CFR240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 9, 2016, Jeffrey
Potrzebowski, Chief Financial Officer and Vice President of Finance of Bioanalytical Systems, Inc. (the &quot;Company&quot;), retired
from these positions, effective immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also on May 9, 2016,
the Board of Directors of the Company appointed Jill C. Blumhoff as Chief Financial Officer and Vice President of Finance of the
Company. Ms. Blumhoff, age 39, joined the Company in October 2007 as Assistant Controller and has served as Director of Finance,
Tax and IT since 2013. Before joining BASi, Ms. Blumhoff held various roles of increasing responsibility in financial reporting
and analysis at Wabash National Corporation, in Lafayette Indiana. Ms. Blumhoff began her career at Ernst &amp; Young LLP. She
earned a Bachelor of Science degree in accounting from the University of Illinois at Urbana-Champaign. There are no family relationships
between Ms. Blumhoff and any of the Company&rsquo;s officers or directors. Nor are there any transactions between Ms. Blumhoff
and the Company that would be required to be reported under Item 404(a) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
her appointment, the Company and Ms. Blumhoff entered into an employment agreement (the &quot;Employment Agreement&quot;) effective
May 13, 2016. The term of the Employment Agreement extends through April 30, 2018, subject to automatic renewal for successive
one-year terms unless either party gives the other written notice of their intent to terminate the Employment Agreement at least
90 days before the end of the then current term. The Employment Agreement provides that Ms. Blumhoff&rsquo;s base salary will be
$12,500 per month. Ms. Blumhoff is also eligible for an annual cash bonus based upon the Company's Annual Incentive Bonus Compensation
Program or successor plans thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Employment
Agreement, the Company granted Ms. Blumhoff an option to purchase 10,000 of the Company&rsquo;s common shares at a price of $0.94
(the closing price of the Company's common shares on May 12, 2016) pursuant to the Company's 2008 Director and Employee Stock Option
Plan and an Option Agreement dated May 13, 2016. The options will vest and become exercisable in three equal annual installments
on the first, second and third anniversaries of the grant date, subject to the conditions set forth in the Stock Option Plan and
related agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms. Blumhoff remains
entitled to the benefits provided under her retention and severance agreement entered into on November 9, 2015 (the &quot;Retention
and Severance Agreement&quot;), a form of which was filed as exhibit 10.1 to the Company&rsquo;s Form 8-K filed November 19, 2015.
In addition, under her Employment Agreement, (i) if Ms. Blumhoff&rsquo;s terminates her employment for &quot;good reason&quot;
(as defined in the Employment Agreement) she would be entitled to monthly reimbursement of COBRA premiums, if any, for a period
of six months and, if such termination takes place outside of in the context of a &quot;Change in Control&quot; (as defined and
governed by her Retention and Severance Agreement), Ms. Blumhoff would be entitled to (a) six months base salary at her then current
salary payable in equal bi-weekly installments over the six month period following the termination date and (b) a pro-rated portion
of the annual bonus she was eligible for, if any, for the completed portion of any fiscal year in which the termination date occurs
and (ii) if Ms. Blumhoff&rsquo;s employment is terminated by the Company &quot;without cause&quot; (as defined in the Employment
Agreement), in addition to the compensation payable under her Retention and Severance Agreement, Ms. Blumhoff would be entitled
to (a) a pro-rated bonus for the completed portion of the fiscal year in which the termination occurs and (b) monthly reimbursement
of COBRA premiums, if any, for a period of six months. In exchange for these arrangements, Ms. Blumhoff has agreed not to solicit
the Company's customers or employees for a period of two years following the date of her termination or resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary
of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements
and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;Exhibits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">10.1</TD><TD>Employment Agreement, by and between Bioanalytical Systems, Inc. and Jill C. Blumhoff effective May 13, 2016.</TD></TR>                                                                                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>99.1</TD><TD>Bioanalytical Systems, Inc. press release, issued May 11, 2016.</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Bioanalytical Systems, Inc. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: May 13, 2016</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By: <U>/s/ Jill C. Blumhoff</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jill C. Blumhoff</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vice President of Finance</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1.25in; text-align: left"><FONT STYLE="font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Description</U></B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1.25in; text-align: left">10.1</TD><TD STYLE="text-align: justify">Employment Agreement, by and between Bioanalytical Systems,
Inc. and Jill C. Blumhoff effective May 13, 2016.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1.25in; text-align: left">99.1</TD><TD STYLE="text-align: justify">Bioanalytical Systems, Inc. press release, issued May
11, 2016.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v439909_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; border-bottom: rgb(247,150,70) 3pt solid"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 33%; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; border-bottom: rgb(247,150,70) 3pt solid">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="width: 33%; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; border-bottom: rgb(247,150,70) 3pt solid">13 May 2016</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS AGREEMENT (&quot;Agreement&quot;) is made and entered into
effective the 13th day of May, 2016, (the &ldquo;Start Date&rdquo;), by and between BIOANALYTICAL SYSTEMS, INC. a corporation organized
under the laws of the State of Indiana (&ldquo;BASi&rdquo; or the &ldquo;Company&rdquo;), and Jill C. Blumhoff, an individual residing
in the State of Indiana (&quot;Employee&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Preliminary Statements:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A. BASi is engaged in the business of providing
contract research services and manufacturing and distributing scientific instruments (the &ldquo;Business&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">B. Employee is experienced in the Business,
and is familiar with the management and operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C. The Company wishes to employ Employee
on the terms and conditions contained herein and Employee views entry into this employment as a mutually beneficial long-term investment
by both the Company and by the Employee as a major career commitment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of
the premises and mutual covenants and agreements contained herein, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ARTICLE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Term, Compensation, and Benefits</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1.1</U>.&nbsp;<U>Term</U>&nbsp;The
Company hereby agrees to employ the Employee, and the Employee hereby accepts employment with the Company, on the terms and conditions
set forth in this Agreement until <B>April 30, 2018</B> (the &ldquo;Initial Term&rdquo;). The Initial Term shall be extended for
successive one year periods (the &quot;Additional Terms,&quot; and together with the Initial Term, the &quot;Employment Period&quot;),
except that if either Employee or the Company gives the other party written notice at least ninety days (90) before the end of
the Initial Term or any Additional Term, as the case may be, then this Agreement shall expire at the end of its then current term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1.2</U>&nbsp;<U>Compensation
and Benefits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1.2.1</U>&nbsp;<U>Salary</U>:
BASi will pay the Employee a base salary at a rate of not less than $12,500 per month from the Start Date until adjusted by the
Compensation Committee of the Board of Directors of the Company (the &ldquo;Board&rdquo;). Salary shall be paid in equal bi-weekly
installments in arrears. All amounts to be paid hereunder shall be paid in accordance with normal payroll procedures of the Company
and shall be subject to all required withholdings and deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1.2.2. Stock
Options:</U>&nbsp;On the Start Date, the Employee shall receive a grant of options to purchase 10,000 BASi shares under the Company's
2008 Director and Employee Stock Option Plan (the &ldquo;Option Plan&rdquo;), on the terms and conditions of an option agreement
to be entered into by the Employee and the Company. The Employee will be eligible to receive additional option grants and other
equity awards from time to time during the Employment Period as determined by the Board or any committee thereof. The exact number,
strike price, vesting schedule and other terms of any such options or equity awards will be set forth in appropriate agreements
between the Company and Employee as required by the Option Plan or any additional or successor plan hereafter adopted by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1.2.3</U>.&nbsp;
As Chief Financial Officer and Vice President of Finance, the Employee will be eligible to participate in the Annual Incentive
Bonus Compensation Program. The Employee will also be eligible for bonus grants under any other bonus plans adopted by the Company
at the discretion of the Compensation Committee of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; width: 34%"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; width: 33%">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; width: 33%">13 May 2016</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><U>Section 1.2.4</U>&nbsp;<U>Vacation
Policy</U>:<B>&nbsp;</B>Employee will be subject to the Company's vacation policy as outlined in the Company's Employee Handbook,
provided however,&nbsp;the Employee shall take absences at such time as shall be approved by the Company's Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1.2.6</U>&nbsp;<U>Other
Benefits</U>: During the Employment Period, the Employee shall be entitled to participate in all employee benefit plans which are
generally made available to employees of the Company, subject to the eligibility, qualification, waiting period and other terms
and conditions of such plans as they shall be in effect from time to time unless listed herein as exceptions from those terms and
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ARTICLE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Duties</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2.1.</U>&nbsp;<U>Duties</U>.&nbsp;During
the Employment Period the Employee will serve as Chief Financial Officer and Vice President of Finance of the Company. In her role
as Chief Financial Officer and Vice President of Finance the Employee will be the ranking financial officer of the Company. The
Employee will lead the financial services and Information Technology staff and, subject to supervision by the Chief Executive Officer
and the Board, be the ultimate financial contact with clients, auditors and banks and own responsibility for assisting the Senior
Management Team on all strategic and tactical matters as related to budget management, cost benefit analysis, forecasting needs,
securing appropriate funding, and positioning the Company for growth. In addition, the Employee is responsible for strengthening
existing collaborations, building new partnerships, and executing programs and initiatives to support BASi's mission statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2.2.</U>
<U>Other Duties</U>. The Employee shall serve the Company by performing such other services as the Company may reasonably require
to conduct the Company&rsquo;s business. The Company shall also have the absolute right and power to direct and control the Employee
in carrying out duties assigned by the Company, including, but not limited to, the right (1) to review, modify and cancel all work
performed, and (2) to assign specific duties to be performed, including the general means and manner by which such duties shall
be performed. Notwithstanding any other provisions of this Agreement, the Company shall not impose employment duties or constraints
of any kind upon the Employee which would require the Employee to violate any ordinance, regulation, statute or other law. The
Employee shall devote her full working time, attention and energy to the performance of the duties imposed hereunder. The Employee
shall conform to such hours of work as may from time to time reasonably be required of her and shall not be entitled to receive
any additional remuneration for work outside her normal hours. The Employee will&nbsp;not&nbsp;be held financially, legally, or
otherwise liable for any practice or action or decision made by BASi, or its predecessors or successors prior to the Start Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.3&nbsp;<U>Officer
Indemnification</U>. Employee shall be entitled to indemnification as provided for the Company's directors and officers in its
articles of incorporation and bylaws, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Confidentiality and Other Matters</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3.1</U>.&nbsp;<U>Confidentiality
Agreement</U>. The Employee, prior to and during the term of employment under this Agreement, has had and will have access to and
has become or will become familiar with information, whether or not originated by the Employee, which is used in or related to
the Business or the business of BASi or certain subsidiaries or affiliates of BASi and is (a) proprietary to, about, or created
by the Company its subsidiaries or its affiliates; (b) designated as confidential by the Company, its subsidiaries or its affiliates;
or (c) not generally known to or ascertainable by proper means by the public (&quot;Confidential Information&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, the Employee
has had and will have access to items proprietary to the Company, its subsidiaries or its affiliates (&quot;Proprietary Items&quot;).
&quot;Proprietary Items&quot; shall mean all legally-recognized rights which result from or are derived from the Employee's work
product or the work product of others made for the Company, its subsidiaries or its affiliates, including all past, present and
future work product made for the Company, its subsidiaries or its affiliates, or with knowledge, use or incorporation of Confidential
Information, including, but not limited to works of authorship, developments, inventions, innovations, designs, discoveries, improvements,
trade secrets, trademarks, applications, techniques, know-how and ideas, whether or not patentable or copyrightable, conceived
or made or developed by the Employee (solely or in cooperation with others) or others during the term of this Agreement or prior
to or during her tenure with the Company, or which are reasonably related to the Business or the business of BASi or certain subsidiaries
or affiliates of BASi or the actual or demonstrably anticipated research and development of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; width: 34%"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; width: 33%">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; width: 33%">13 May 2016</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employee agrees
that any Confidential Information and Proprietary Items will be treated in full confidence and shall not be used, directly or indirectly,
by her nor shall the same be disclosed to any other firms, organizations, or persons outside of the Company's employees bound by
similar agreement, during the term of this Agreement or at any time thereafter, except as required in the course of her employment
with the Company. All Confidential Information and Proprietary Items, whether prepared by the Employee or otherwise, coming into
her possession, shall remain the exclusive property of the Company and shall not be permanently removed from the premises of the
Company under any circumstances whatsoever, without the prior written consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employee will not be obliged to keep
information confidential to the extent that the information has ceased to be confidential and has entered the public domain otherwise
than due to the Employee's acts. In addition, as provided by federal law (18 U.S.C. &sect;1833), Employee shall not be held criminally
or civilly liable under any Federal or State trade secret law for her disclosure of a trade secret that is made by her: (a) in
confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and solely for
the purpose of reporting or investigating a suspected violation of law or (b) in a complaint or other document filed by her in
a lawsuit or other proceeding, on the condition that such filing is made under seal. The provisions of this Section 3.1 shall be
in addition to, and shall not affect, the Employee's common law duty of fidelity to the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3.2</U>.
<U>Disclosure and Assignment of Inventions</U>. The parties foresee that the Employee may make inventions or create other intellectual
property in the course of her duties hereunder and agree that in this respect the Employee has a special responsibility to further
the interests of the Company and its affiliates. The Employee acknowledges and agrees that all such inventions and other intellectual
property is and shall remain the exclusive property of the Company, whether or not prepared in whole or in part by the Employee
and the Employee agrees to disclose to the Company all such items. Upon the termination of the Employee's employment with Company
(regardless of the reason), or at any other time at the request of the Company, the Employee shall immediately deliver to the Company
all such inventions and intellectual property, in the possession of the Employee.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3.3</U>.
<U>Non-Solicitation</U>. The Employee agrees that during the Employee&rsquo;s employment with the Company and for an additional
period of the two (2) years immediately following termination of the Employee&rsquo;s employment with the Company, the Employee
shall not directly or indirectly, as an individual or as a director, officer, contractor, employee, consultant, partner, investor
or in any other capacity with any corporation, partnership or other person or entity, other than the Company (an &ldquo;Other Entity&rdquo;),
(i) contact or communicate with any then current material customer or client of the Company in the Business, or any person or entity
with which the Company is then engaged in material discussions regarding that person or entity becoming a client or customer of
the Company in the Business, for the purpose of inducing any such customer or client to move its account from the Company to another
company in the Business; provided, however, that nothing in this sentence shall prevent the Employee from becoming employed by
or providing consulting services to any such customer or client of the Company in the Business, or (ii) solicit any other employee
of the Company for employment or a consulting or other services arrangement with an Other Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The restrictions of
this&nbsp;<U>Section 3.3</U>&nbsp;shall not be deemed to prevent the Employee from owning not more than 5% of the issued and outstanding
shares of any class of securities of an issuer whose securities are listed on a national securities exchange or registered pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as amended. In the event a court of competent jurisdiction determines
that the foregoing restriction is unreasonable in terms of geographic scope or otherwise then the court is hereby authorized to
reduce the scope of said restriction and enforce this&nbsp;<U>Section 3.3</U>&nbsp;as so reduced. If any sentence, word or provision
of this&nbsp;<U>Section 3.3</U>&nbsp;shall be determined to be unenforceable, the same shall be severed herefrom and the remainder
shall be enforced as if the unenforceable sentence, word or provision did not exist. Notwithstanding any provision of this Agreement
to the contrary, the terms and conditions of this&nbsp;<U>Section 3.3</U>&nbsp;shall survive for a period of two (2) years following
termination of the Employee&rsquo;s employment with the Company, at which time the terms and conditions of this&nbsp;<U>Section
3.3</U>&nbsp;shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3.4</U>.
<U>Code of Conduct</U>. The Employee agrees to abide by all the conditions of the Company Code of Conduct and Ethics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; width: 34%"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; width: 33%">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; width: 33%">13 May 2016</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ARTICLE 4</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Termination of Employment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4.1</U>.&nbsp;<U>Resignation
by the Employee</U>. The Employee may resign from her employment with the Company at any time providing written notice to the Company
of resignation at least ninety days (90) prior to the effective date of the resignation (the &ldquo;Resignation Date&rdquo;). Employee
may resign at any time for &ldquo; good reason&rdquo; due to (a) a material breach of this Agreement by the Company and the Company
has not rectified such breach within thirty (30 days after the Employee has given the Company written notice of such breach, or
(b) the assignment to the Employee of duties materially inconsistent with this Agreement other than in accordance with the terms
of this Agreement, and the Company has not rectified such assignment within thirty days (30) after the Employee has given the Company
written notice of such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A termination by the
Employee for &ldquo;good reason&rdquo; shall entitle the Employee to the same compensation and benefits as if the Employee had
been terminated by the Company without cause. Upon any resignation by the Employee, the Employee shall use reasonable best efforts
to assist the Company in good faith to effect a smooth transition. If the Employee voluntarily resigns her position without &ldquo;good
reason&rdquo; prior to the termination of this contract, the compensation terms of this agreement are null and void. Notwithstanding
the foregoing, following a termination for &ldquo;Good Reason&rdquo; after a &ldquo;Change in Control&rdquo;, each as defined in
that certain Key Employee Agreement, dated November 9, 2015, by and between the Employee and the Company (the &ldquo;Key Employee
Agreement&rdquo;), the terms and conditions of the Key Employee Agreement shall apply and no compensation shall be due hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4.2</U>.&nbsp;<U>Termination
by the Company without Cause</U>. At any time, the Company may, in its sole and absolute discretion, terminate the Employee's employment
with the Company (the actual date of termination being referred to as the &quot;Termination Date&quot;) without cause, by providing
written notice thereof to the Employee (&quot;Termination Notice&quot;) at least ten days (10) prior to the Termination Date. In
the event of termination of the Employee's employment pursuant to this Section, the Company shall continue to pay to the Employee
the Employee&rsquo;s then current annual salary, in no cases less than $12,500 per month, throughout such ten-day (10) notice period
and shall pay the Employee as compensation for loss of office (a) six (6) months base salary at the Employee&rsquo;s then current
salary in equal bi-weekly installments over the six (6) month period following the Termination Date (provided however, that if
payments under the Employee's Key Employee Agreement are triggered based on such termination, no such payments will be due hereunder)
, (b) a pro-rated portion of the annual bonus the Employee was eligible for, if any, for the completed portion of any fiscal year
in which the Termination Date occurs (payable whether or not compensation is due under the Key Employee Agreement for such termination,
and based on the relevant portion of the bonus that would have been earned, if any, had the Employee remained employed through
the fiscal year and payable at the time payable were the Employee to have remained employed) and (c) all vacation accrued as of
the Termination Date calculated in accordance with&nbsp;<U>Section 1.2.4</U>.&nbsp;Upon receipt by the Employee of a Termination
Notice pursuant to this&nbsp;<U>Section 4.2</U>, (a) the Employee shall assist the Company in good faith to effect a smooth transition,
and (b) the Company may request the Employee to vacate the premises owned by the Company and used in connection with the Business
within a reasonable time, provided that the obligation of the Company to make payments to the Employee pursuant to this&nbsp;<U>Section
4.2</U>&nbsp;and the other provisions of this Agreement shall not be affected. Amounts payable pursuant to clauses (a) and (b)
of this <U>Section 4.2</U> shall be payable only following the delivery to the Company by the Employee of a duly executed release,
in form and substance acceptable to the Company, of all claims the Employee may have against the Company, which release is no longer
subject to revocation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4.3</U>.&nbsp;<U>Termination
by the Company With Cause</U>. This Agreement shall be deemed to be terminated with cause and the employment relationship between
the Employee and the Company shall be deemed severed upon written notice to the Employee by the Company after the occurrence of
any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">a conviction (or entry of a plea of nolo contendre thereof) for a felony or conviction (or entry
of a plea of nolo contendre thereof) for any crime or offense lesser than a felony involving misappropriation of the property of
the Company, an Affiliated Employer (as defined in the Key Employee Agreement) or a related entity, whether such conviction or
plea occurs before or after termination of employment with the Employer (as defined in the Key Employee Agreement).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; width: 34%"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; width: 33%">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; width: 33%">13 May 2016</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">engaging in conduct that has caused demonstrable and material injury to the Company or an Affiliated
Employer (as defined in the Key Employee Agreement) or a related entity, monetary or otherwise.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">failure to follow the reasonable instructions of the Board, the Chief Executive Officer, or the
Employee's immediate supervisor relating to the Employee's employment or the performance of the Employee's duties and responsibilities.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">dereliction or other misconduct in the performance of the Employee's duties for the Company or
an Affiliated Employer (as defined in the Key Employee Agreement) and the failure to cure such situation within thirty (30) days
after receiving written notice thereof from the Board or the Chief Executive Officer.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify">the intentional disclosure or use of Confidential Information (as defined in the Key Employee Agreement)
to a party unrelated to the Company or an Affiliated Employer (as defined in the Key Employee Agreement) other than as determined
in good faith by the Employee to be not contrary to the interests of the Company or believed by the Employee to be required by
law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement and the Employee's employment with the Company
shall terminate upon the death or Disability of the Employee. For purposes of this Agreement, &quot;Disability&quot; means a disability
as determined for purposes of the current group disability insurance policy of the Company or an Affiliated Employer in effect
for the Employee which qualifies the Employee for long-term disability insurance payments in accordance with such policy, or if
there is no such policy, then means that a current <I>sickness </I>or <I>injury </I>causes physical or mental impairment to such
a degree that you are: (1) not able to perform, on a full-time basis, the major duties of your <I>own occupation and </I>(2) not
able to perform, on a full-time basis, the major duties of any <I>gainful work</I>. .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Employee's employment is terminated
by the Company for cause pursuant to this <U>Section 4.3</U> or is terminated due to death or Disability, the Company shall pay
to the Employee any unpaid base salary for the period ending on the termination date, plus the amount of any accrued vacation as
of the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4.4</U>.&nbsp;<U>Continuation
of Health Insurance Benefits</U>. If the Employee is terminated by the Company without cause, or terminated her employment with
the Company for &ldquo;good reason&rdquo;, and provided that the Employee elects continuation of health coverage pursuant to Section
601 through 608 of the Employee Retirement Income Security Act of 1974, as amended (&ldquo;COBRA&rdquo;), the Company shall reimburse
the Employee an amount equal to her monthly COBRA premiums for a period of six (6) months after termination; provided further,
such payments will cease upon the Employee&rsquo;s becoming entitled to other health insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ARTICLE 5</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Miscellaneous</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.1</U>.&nbsp;<U>Relationship
between the Parties</U>. The relationship between the Company and the Employee shall be that of an employer and an employee, and
nothing contained herein shall be construed or deemed to give the Employee any interest in any of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.2</U>.&nbsp;<U>Notices</U>.
Any notice required or permitted to be given under this Agreement shall be in writing and delivered personally or sent by certified
mail, addressed to the party entitled to receive said notice, at the following addresses:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="margin-left: 0.5in; border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 26%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0in; padding-left: 0in">If to Company:</TD>
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Bioanalytical Systems Inc.</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2701 Kent Avenue</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">West Lafayette, IN 47906</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; width: 34%"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; width: 33%">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; width: 33%">13 May 2016</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="margin-left: 0.5in; border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 26%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0in; padding-left: 0in">If to Employee:</TD>
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jill C. Blumhoff</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2701 Kent Avenue</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">West Lafayette, IN 47906</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or at such other address as may be specified
from time to time in notices given in accordance with the provisions of this&nbsp;<U>Section 5.2.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section
5.3&nbsp;Enforceability</U>. Both the Company and the Employee stipulate and agree that if any portion, paragraph sentence, term
or provision of this Agreement shall to any extent be declared illegal, invalid or unenforceable by a duly authorized court of
competent jurisdiction, then, (a) the remainder of this Agreement or the application of such portion, paragraph, sentence, term
or provision in circumstances other than those as to which it is so declared illegal, invalid or unenforceable, shall not be affected
thereby, (b) this Agreement shall be construed in all respects as if the illegal, invalid or unenforceable matter had been omitted
and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law and (c)
the illegal, invalid or unenforceable portion, paragraph, sentence, term or provision shall be replaced by a legal, valid and enforceable
provision which most closely reflects the intention of the parties hereto as reflected herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.4</U>.&nbsp;<U>Nonwaiver</U>.
The failure of either party hereto to insist in any one or more instances upon performance of any of the provisions of this Agreement
or to pursue its or his rights hereunder shall not be construed as a waiver of any such provisions or as the relinquishment of
any such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.5</U>.&nbsp;<U>Succession</U>.
This Agreement shall inure to the benefit of and be binding upon the parties hereto and upon their heirs, personal representatives,
and successor entities. This Agreement may not be assigned by either party without prior written agreement of both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.6</U>.&nbsp;<U>Governing</U>&nbsp;<U>Law</U>.
The laws of the United States and the State of Indiana shall govern the construction and enforceability of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.7</U>.&nbsp;<U>Entire
Agreement</U>. This Agreement and the Key Employee Agreement constitute the entire agreement between the parties as to the subject
matter contained herein and all other agreements or understandings are hereby superseded and terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.8</U>.&nbsp;<U>Collective
Agreements</U>. There are no collective agreements which directly affect the terms and conditions of the Employee's employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.9</U>.&nbsp;<U>Grievance
and Disciplinary Procedures</U>. If the Employee wishes to obtain redress of any grievance relating to her employment or if she
is dissatisfied with any reprimand, suspension or other disciplinary steps taken by the Company, she shall apply in writing to
the Chief Executive Officer of the Company, setting out the nature and details of any such grievance or dissatisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.10</U>.&nbsp;<U>Heading</U>.
The headings of the sections are inserted for convenience only and do not affect the interpretation or construction of the sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5.11.</U>&nbsp;<U>Remedies</U>.
Employee acknowledges that a remedy at law for any breach or threatened breach of the provisions of <U>Sections 3.1</U> through
<U>3.3</U> of this Agreement would be inadequate and therefore agrees that the Company shall be entitled to injunctive relief,
both preliminary and permanent, in addition to any other available rights and remedies in case of any such breach or threatened
breach; provided, however, that nothing contained herein shall be construed as prohibiting the Company from pursuing any other
remedies available for any such breach or threatened breach. Employee further acknowledges and agrees that in the event of a breach
by Employee of any provision of <U>Sections 3.1</U> through <U>3.3</U> of this Agreement, the Company shall be entitled, in addition
to all other remedies to which the Company may be entitled under this Agreement to recover from Employee its reasonable costs including
attorney's fees if the Company is the prevailing party in an action by the Company. This Agreement is entered into by the Company
for itself and in trust for each of its affiliates with the intention that each company will be entitled to enforce the terms of
this Agreement directly against Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; width: 34%"><IMG SRC="logo3.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-align: center; vertical-align: bottom; width: 33%">EMPLOYEE AGREEMENT</TD>
    <TD STYLE="border-bottom: rgb(247,150,70) 3pt solid; padding: 0 0 5pt; font-size: 10pt; text-indent: 0; text-align: right; vertical-align: bottom; width: 33%">13 May 2016</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the Company and the Employee have executed,
or caused to be executed, this Agreement as of the day and year first written above.&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">&ldquo;COMPANY&rdquo;</TD><TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">EMPLOYEE</TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">/s/ Jacqueline M. Lemke</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">/s/ Jill C. Blumhoff</TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jacqueline M. Lemke</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jill C. Blumhoff</TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">President and CEO, Bioanalytical Systems, Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"></TD></TR>
</TABLE>




<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-top: 5pt; border-top: rgb(247,150,70) 3pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"><P STYLE="margin: 0pt 0">Confidential</P></TD><TD STYLE="width: 50%; text-align: right">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v439909_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-size: 10pt; text-indent: 0"><IMG SRC="logo1.jpg" ALT="">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; font-size: 10pt; text-indent: 0; text-align: right">&nbsp;<IMG SRC="logo2.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0; width: 48%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></TD>
    <TD STYLE="padding: 0; font-size: 10pt; text-indent: 0; width: 29%"><FONT STYLE="font-size: 10pt">FOR MORE INFORMATION</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; text-align: right; width: 23%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Jeffrey Potrzebowski</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Chief Financial Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Phone: 765.497.8409</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: blue; text-align: right"><U>jpotrzebowski@BASinc.com</U></P></TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>




<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 0; text-align: center"><B>Bioanalytical Systems, Inc.
Announces Appointment of New Chief Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.8pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>WEST LAFAYETTE, IN </B>&ndash;
May 11, 2016 -- <B>Bioanalytical Systems, Inc. (NASDAQ:BASI) (&ldquo;BASi&rdquo; or the &ldquo;Company</B>&rdquo;) on May 9, 2016,
the Board of Directors of the Company approved<B> </B>the appointment of Jill C. Blumhoff, age 39, as Chief Financial Officer (CFO)
and Vice President of Finance of the Company. Ms. Blumhoff succeeds Jeffrey Potrzebowski, age 63, effective with his retirement
from the Company on May 9, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.9pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Ms. Blumhoff joined BASi in
October 2007 as Assistant Controller and has served as Director of Finance, Tax and IT since 2013. In her role, Ms. Blumhoff has
been responsible for all aspects of financial reporting and disclosure in addition to leading the Company&rsquo;s efforts in building
the financial support structure at BASi. Before joining BASi, Ms. Blumhoff held various roles of increasing responsibility in financial
reporting and analysis at Wabash National Corporation, in Lafayette Indiana. Ms. Blumhoff began her career at Ernst &amp; Young
LLP. She earned a Bachelor of Science degree in accounting from the University of Illinois at Urbana-Champaign.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&ldquo;Jill is a valued member
of the finance team who has been instrumental in guiding BASi during a period of significant change at our Company,&rdquo; said
Jacqueline M. Lemke, BASi President &amp; Chief Executive Officer. &ldquo;Jill&rsquo;s knowledge and understanding of BASi&rsquo;s
business as well as her leadership of the financial team in support all areas of the operations, will enable BASi to focus on our
highest-potential growth opportunities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 23.4pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&ldquo;Mr. Potrzebowski came
to BASi in June of 2014 with a wealth of prior experience and did an excellent job as a senior leader both managing the financial
team and contributing to all aspects of the Company. I would like to thank him for his hard work and dedication and wish him well
in his future endeavors,&rdquo; said Jacqueline M. Lemke, BASi President &amp; Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 23.4pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Mr. Potrzebowski will be available
to consult with Ms. Blumhoff in order to ensure a seamless transition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.9pt 0pt 0"><B>About Bioanalytical Systems, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">BASi is a pharmaceutical development
company providing contract research services and monitoring instruments to the world's leading drug development companies and medical
research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce
the cost of taking a new drug to market. Visit <FONT STYLE="color: blue"> www.BASinc.com </FONT>for more about BASi.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><I>This release may contain forward-looking
statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes
in the market and demand for our products and services, the development, marketing and sales of products and services, changes
in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings
with the Securities and Exchange Commission.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 43.9pt 0pt 21.45pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 43.9pt 0pt 21.45pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I>&nbsp;<IMG SRC="footer.jpg" ALT=""></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I>&nbsp;</I></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < '@# 2(  A$! Q$!_\0
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MRLI+<K\I!#9.2.<9KL/^">W[5NO?'W3M6TCQ)Y=UJ.CQQRQ7J($:>,G:0X4
M;@<8( R"<\C)\S_;SU_XF>,=#TV/Q9X6D\,^";6Y6:>33ITU)A(05!=@R#@,
M0 0@);J3C'JW_!/YOA?I7A*]M/!&I7%YK$P674O[000WC*OW?D!*^6I;^$M@
MMR<XHRFM-<:.G@*DJ.'MK3J.4>=\K^"G/7>SNDK6?HS-Z,'P4JF/IQK8CF]V
MI349<BYE\=2&FUU:[O=)]U>_;^^)6K:#\-(?"_AI;B;Q%XF\UPML<2QVENAE
MF<?4*!CNN_'(KQ?_ ()C?M#7D?CS4?!NM7TUPNL*;BQ,\A8I/&"609_O("?^
MV8'>O5OA=\1O#_B7XS>)OB9XFUO2=*TEF;P[X9-_=)"L]O"09Y4W$!@S,"".
M1O937QS\8A8? []I6;4O!>L:=?Z;9WR:AIEQ8W"S11KN$BQDH<?(?E()Y"\\
M&O+XJSNOA<UP_%%*K>FIN'(FK^R6BE:__+SWY)OHX'J<)Y'0Q>58GA>K2M4<
M%/VC3M[7=QYMOW?N1:3W4S[>_;Y_:'U+X"?"ZS717%OJNO7#6Z7.,FUB4 NZ
MCD;OF4#/0$GJ!3?@M^SI\-_BO\+-)UR]A;QE?:I:QO=ZG?7LLUP9MH+KG?F,
MJV1M7!&.23R;OQ?^%^D_MU?LYZ3=65RME<74:ZAI\[?,MO-M*O"^.P.5;'1D
M!P<8/Q1<Z7\5OV'?%WF+_:6CJSX$D?[VQO@.<=T?@=#RH/0&O:XISFIE^<?V
MGF&'^LX"I"/(TE)0OJW9^[>7=V;324M&CQ.%<EI9AD[RS+\3]6Q].<N=-N+G
M;1*Z]ZT;;*Z33;CJF?8W@;]F74/A+^U!INK:?J&KZIX4FTZYBCCO+DS?V3(=
MGR L<[7[$#/RD'H"?,O^"AGP5^)7Q#^*VD7GA^UU/5-$C@C6UCM&++9S@G<S
M*/NDY!WG@C S\O'>?LC_ +>MG^T!=+X>UJ"WT?Q2T9\AH\FVO2%R=H)RK#!.
MTDY //:O-OVQ/VFOBQ^SY\0[?0E\1Z5)#?6J7<-Q::7'&VQG=,%9/,PP*'HQ
M['V$Y[B.')\-3JX>53ZM4J<S=.UX3LO<:DTTM+I.Z6EK+E+R'#\20XFA2Q$:
M?UJG3Y4JE[3A=^^G%--ZV;T;UOKS'UE\'M*UK0OA9X?L_$5P;K7+:QBCO9"_
MF,T@7G+?Q,.A;G)!/>BCX-ZW=>)?A%X5U&^F:XO=0TBTN;B4@ R2/"C,V!@#
M))/'%%?LF7\GU6E[.]N6-KZNUE:[ZOOYGXSF'/\ 6JOM+7YI7MHKW=[+HNWD
M9/QI^#:_$J'3]3TZX32_%GAZ3[3I&H[<^4_>*3^]$XX8>AZ'D&/XB_!FU_:#
M^%-KI?B^S6PU942YCN+"8^=I-XHR);>7&0RG\".#D=>^HHI8&E3Q$\33TE-+
MF2V;6B;7\R6E^JLG>RL5,=5J8>&&J:J#?+?=)[I/^5O6W1W:M=W_ #-_;&^&
M_P"TIX6T^;P[JVL>)/&7@]B%BN].C,B7"#H)P@\S(P"1*2,]"V,UJ?\ !*[]
MCWQEI/QNM?'>O:3J&@Z/HL$PM_MD30R7LLD;Q85& )0*[,6Z9  SDX_1ZBN[
MFTL</*>3_MQ7T-A^RSXN::1(ED@B12QQN8S1X ]Z^5_^"3G_ "7+6_\ L!R_
M^C[>OL_X@_ 'PC\5=2CN_$.CIJDT:[4\VXE"(/90P4'WQFJ'A_\ 9:^'_A6*
M_33_  S9VJZI:M976R23,L+,K,F2V0"44\8Z"OS/.N$\QQO$F'SJ#@H459)R
ME>5N9Z^Y97<K=;6OKL?IV2\79=@N&\1DLU-SK.[DHQM&_*M/?N](WZ7O;3<H
M_M??$#0?!'P!\41ZU=6J-J6G3VEK;NP\RXF="J;5ZG#$,2/NA<]J^(O^"=_@
M'6/%/[1NGWUE;3#2=/CF?4)2"(A$\3H$;L=Q; '7J1]TD?;MM^QE\,+67>O@
M_3V;.?GDED!^H9B#7?>&?">E^"M*2QT?3;'2[*/[L%I L,8]\* ,^]3FG!N.
MS?.L/F>/E"G"A9J,'*4I-/FUDXPLKVZ/2_>Y65\:8')\DQ.5X",ZDZ]TY348
MQBFN72*E*[M?=[V[6.<\+? /POX?\ Z)X?N-%TK5K;0[?R86O;..=MQ^:1QN
M!P7;+''4FO"/^"C'[-.AO\$5\1:#H^DZ1=>'9U:86=K';^?#*RH00H&XARA&
M>@W^M?55<A\2?@1X5^+T\;^(]-DU(0J%2-KV>.(8SSY:.%SR><9]Z^AXBX9H
M8W*JF7X>E"\H\L;Z<MDN5W49/W;*RMK:VA\[PYQ1B,#FM/,,15G:,N:26O-=
M^\K.45[UW=WTO>S/EG_@F+^T1!HWA;Q!X4UBX9;?2XVU:T;!8I$,"=0!V'RO
MM&2?WAKZ]N3H7Q&\)/YITO6M#OHOF+%)[:9#Z]5(KD?!O[)GP]^'WB6UUC1_
M#<%CJ5F6,,RW,[%-RE3PSD'*L1@CH359OV,?A@T_F?\ "'Z?NR#CS)=IQT^7
M?CCTQ7F<,Y1GF5Y93R[$*E64;K64E[OV5?V;ONU:RLDM7JEZG$^<9%FF:5,Q
MP_M:+E:6D8OWOM.WM(VV3O=W;>BT;^1/#/P0L]2_;]AL_AW(]QX?T35;>_FN
M86,D-I&A225?,[J&#H#GDX&3U-S_ (*MW$;_ !YT%5D4M'HL.\ \K^_N#S^%
M?=/A3P+HO@32C8Z+I=AI-JQRT5I L*L?4[0,GW/-<1>_L=?#74[R2XNO"UK=
M7$S;I)9KB>1W/J6+DFOF,=X:8EY/6R["2@I5ZGM)?%&$$G=1@DI-I;7;7IT7
MT^ \3<,LXH9CBXS<:%/V<?AE.;:LY3DW%)O>R3]>KW/V>9DG^ G@EHV61?["
MLAE3D9$" _D>**N_#KX2^'OA-936_A[3QIMO<,&>))I'CR,G(5F(7J<XQGO1
M7ZOEM*K2PM.E72YHQ2=FVM%;1M)_@?DV95:57%U*M!OEE)M723U=]4FU^)__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !% .\# 2(  A$! Q$!_\0
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MR-^TAB2#@$8&3E?L^(.(,'DV#EC<:[16B2U<F]DEW?W6NWH?&<.\/8S.L;'
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GX2TK0YXY++2]/LY(8?LT;P6R1LD6XMY8( PNXD[1QDD]:** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  O 0 # 2(  A$! Q$!_\0
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M?\+Q_P"%>^9<_P#"2?V%_P )%L\H^3]D^T?9\[^F[S/X?3FNKKYU_P"<M/\
MW2/_ -S-?15>3E6-J8GVWM+>Y4E%6[*UOF>QF^!IX;V/L[^_3C)W[N][>6@4
M445ZQXX4444 %%%% !117E?PF_;:^%_QR\9_\(]X6\5V^J:PR/(ML;.X@,BH
M,ML:2-5; !/RD\ GI0!ZI17"_%+]I7P3\%?%.AZ+XFUQ-+U/Q(_EZ=";::7S
MVWJG+1HRH-S 9<@<^QK-^-G[87PY_9TU^TTOQEXB&CW]];_:H8OL-S<%XMQ7
M=F*-P/F5A@D'B@#TRBO(/A;^WG\)_C3XZL?#/AGQ7_:6MZEYGV:V_LR\A\S9
M&TC_ #21*HPB,>2.GKQ6_P#"+]J7P'\=_$NK:/X5UY=4U+0^;V#['<0&$;BG
M61%#?,"/E)[>HH ] HKS?XA_M=?#KX4_$JQ\'^(/$L.G^(M1\KR+4VL\@/FM
MMCW2(A1,G^\PP.3@<UTGQ8^+WAWX&^"KCQ%XJU)-)T>V=(Y)VBDE.YV"J D:
ML[$D]@>,GH": .DHK@=6_:B\ Z#\*M.\;7_B6SL?#.K('LKNYCDA:Z!SC9$R
MB1CP3@+G'/2L7X3?MQ?"OXX^+8-!\+^+;?4=8N@YAM7L[FV>;8A=MOFQJ&PJ
ML>.P/I0!ZQ117A>O?\%*O@GX9UR\TV]\;+%>:?.]M.@TF^D"2(Q5AN6$J<$'
MD$@T >Z45QOP<_:$\%_M Z3/>^#_ !!8ZW#:L%G6/='- 3TWQN%=0><$J <'
M'0UPWC7_ (*)_!OX=^+M2T+6/&(M-5TFX>UNX!I5[+Y4J'#+N2$J<'C()% '
MM=%>;_";]KKX=_'+1M?U#PMXB&J6?A>%;C4Y#8W,'V6-ED96Q)&I;(BD/R@_
M=]QG2^"7[1/@W]HS1;S4/!NL#6;/3YA;W#_99K?RW*A@,2HI/!SD#% ';45P
M/QR_:@\"_LV)I;>-==&B_P!LF46?^AW%P9O*V;^(D?&/,3KC[U<CX+_X**_!
MOXA>+=-T+1_&/VS5-7N$M+2#^RKZ/S97(55W/"%&20,D@4 >V45B_$7XBZ+\
M)O!6H>(O$5\FFZ-I:"2YN61G$8+!1\J@L268   DDBN=^!W[3/@?]I&UU&;P
M7KBZU'I+QI=_Z+/;M"7#%,K*B$@[6Y (^4T =Y17*_%KXW^$_@3X?35/%VN6
M.AV<K^7$TY)>9NX1%!=R.^T'%<K\(OVV?A=\=_%$>B^%?%EOJ6K2J[QVKVEQ
M;22!1N;:)8TW87)XSP#Z&@#U2BO(?BG^WE\)_@KXZO?#7B;Q6--UO3Q&;BV&
MFWD_E;XUD7YHXF4Y1U/![UI?!/\ ;#^'/[17B&ZTKP;XB_MC4+*W-W-%]@NK
M?9$&5-V98T!^9E& 2>: .!_YRT_]TC_]S-?15?.O_.6G_ND?_N9KZ*KY[A__
M )B?^OT_T/I.)/\ F%_Z\P_4****^A/FPHHHH **** "OQN^!?A'6O!7PDB^
M,7AM9&U#X?>)XEO53/S6TD:$%N/N;@R-[3U^R-?"O_!'OP=9>.?V<_B-HFK6
MWVC3=6U#['<Q./OH]N%8?7!_ T <S_P4,^(6F_%?XS?L_P#B329?.TW6DANX
M#W4-=0DJWHRG*D=B"*;_ ,%6-?TOPI^VW\,=4UVQ_M+1--LK*ZU"T\E)OM5N
ME_*TL>QR%?<@8;6(!S@\5XCXO\%>)OAE^TAX+^%^JI>7K^#_ !,(M)<H3]HM
M;BYADC\L?W6.Y\#HTC#M7N__  5"\96WPT_;M^$_B2_BN9=/T&"PU&=8%#22
M1PZA)(ZH&(!;:O ) R1DCK0!['^QM^T+\#?CS\6IK'P#\-+?PUX@TC3Y=16_
MD\.V%FT<>Y(7"20NSACYP&. 5+<]CY/\)8?^&;_^"OWB#1=\=KIGC87!C 7$
M9%R@NT4#MB9"@Q].AKW#X"?\%/O /[1/Q7TOP?HFD>,+74]7\[R9;ZTMT@7R
MH7F;<4G=AE8R!A3R1TZUY!_P5JTV[^$WQB^%_P 5M*A62\TJX%O*&3]VS6\J
MSPJQ'9M\P/L.* /G/]M&;5?C%^T!\5/'NGR"33/!^MVNE&:,Y5 -\$3*>F"U
ML3GH=^<],_07_!2KXU2?&K]G'X-Z/I;037WQ$F@U1HXC\RN(EC$9 Z RW!'(
MZQ<=#3?V/OV=IO'W_!-/XCS74<S:IX[>ZOX'9,FX^RX:#CWGCDY_VJ\>_P""
M?-IJGQ__ &G?AGIE\DDFE_#*QGN00O\ JU2>:="Q[?OIHE^B@4 >K?\ !5#X
M&:UX-T7X7WUAIUUKO@CP1IJ:9<6Z;_+@\KRQND"Y\M98T5=XZ;,'^'/H_P"Q
M[\8_V>/C9\1]"O\ P[X3TOP3\0-+A=;*T%N+1GW1.DGEM%B.<^6S\N-Y!SCC
M([[]K#]N^Q_9.\?Z7I.N>$=:U;0]4L1<OJ=DRL(F,CHT6QP$8A5#?ZP?> P.
MI^3/",%G^V%^WKX-\6?"_P !W_A?PWHE_:7NK7;6ZV\,I@G,KR.(R8T=T 3:
MK$L>3G)- 'Z95^57[+OC_P"%?P^_::^)UQ\5K71[O2YYKN.R2_TAM2!G^UDG
M8HC?8VW/S';]:_56OS=_X)_?!WPU\8_VJ_B]I?BO0-.URQ4715+R .8&-Z1N
M1OO1MC(W*0>O- &M_P $S/")\2?MG^-/&'@W2M0TGX;B&[AMC*K1Q.LDJ&*$
M<D,PVEMN3M"\X.,^<VWQ>\ _!?\ X*"_%?5/B-X7_P"$LT2XOM2M8+3^S;>_
M\NX-Y&RR;)V51A$D&X'(WXZ$UZG^PEX@U+]D/]M?Q1\%]6N;J71=7FD.EF4_
M+YBJ9890.0/-@R&P?O!0>G'"^ _VG=!_9*_X*-_%KQ%XDLM9O+*^N-2TZ./3
MH8Y)A(][%*K$2.@V[8FY!SDCCN #ZK^"_P 1_AO\8?V5?B)XB^&_@^W\(V+6
ME[IUY&-)M=/EN9(K3S 6$!8,H$_!)R"6X'?S3_@B/_R1[QI_V&8__1"UZGX
M_;0\+_MB_!?XF+X7T[Q#9MX?T659QJ5O%&9#/!<;-GERR9_U39SCJ.O;X_\
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J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>footer.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 footer.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !9 T4# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**^&?\
MA;WBW_H:/$'_ ('R?XT?\+>\6_\ 0T>(/_ ^3_&OYR_XF.RS_H#J?^!1-O9,
M^YJ*^&?^%O>+?^AH\0?^!\G^-'_"WO%O_0T>(/\ P/D_QH_XF.RS_H#J?^!1
M#V3/N:BOAG_A;WBW_H:/$'_@?)_C1_PM[Q;_ -#1X@_\#Y/\:/\ B8[+/^@.
MI_X%$/9,^YJ*^&?^%O>+?^AH\0?^!\G^-'_"WO%O_0T>(/\ P/D_QH_XF.RS
M_H#J?^!1#V3/N:BOAG_A;WBW_H:/$'_@?)_C1_PM[Q;_ -#1X@_\#Y/\:/\
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M:/\ B8[+/^@.I_X%$/9,^YJ*^&?^%O>+?^AH\0?^!\G^-'_"WO%O_0T>(/\
MP/D_QH_XF.RS_H#J?^!1#V3/N:BOAG_A;WBW_H:/$'_@?)_C1_PM[Q;_ -#1
MX@_\#Y/\:/\ B8[+/^@.I_X%$/9,^YJ*^&?^%O>+?^AH\0?^!\G^-'_"WO%O
M_0T>(/\ P/D_QH_XF.RS_H#J?^!1#V3/N:BOAG_A;WBW_H:/$'_@?)_C1_PM
M[Q;_ -#1X@_\#Y/\:/\ B8[+/^@.I_X%$/9,^YJ*^&?^%O>+?^AH\0?^!\G^
M-'_"WO%O_0T>(/\ P/D_QH_XF.RS_H#J?^!1#V3/N:BOAG_A;WBW_H:/$'_@
M?)_C1_PM[Q;_ -#1X@_\#Y/\:/\ B8[+/^@.I_X%$/9,^YJ*^&?^%O>+?^AH
M\0?^!\G^-'_"WO%O_0T>(/\ P/D_QH_XF.RS_H#J?^!1#V3/N:BOAG_A;WBW
M_H:/$'_@?)_C1_PM[Q;_ -#1X@_\#Y/\:/\ B8[+/^@.I_X%$/9,^YJ*^&?^
M%O>+?^AH\0?^!\G^-'_"WO%O_0T>(/\ P/D_QH_XF.RS_H#J?^!1#V3/N:BO
MAG_A;WBW_H:/$'_@?)_C1_PM[Q;_ -#1X@_\#Y/\:/\ B8[+/^@.I_X%$/9,
M^YJ*^&?^%O>+?^AH\0?^!\G^-'_"WO%O_0T>(/\ P/D_QH_XF.RS_H#J?^!1
M#V3/N:BOAG_A;WBW_H:/$'_@?)_C1_PM[Q;_ -#1X@_\#Y/\:/\ B8[+/^@.
MI_X%$/9,^YJ*^&?^%O>+?^AH\0?^!\G^-'_"WO%O_0T>(/\ P/D_QH_XF.RS
M_H#J?^!1#V3/N:BOAG_A;WBW_H:/$'_@?)_C1_PM[Q;_ -#1X@_\#Y/\:/\
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MK[6]!5*3@DWU"BBBOT(R"BH=0U"WTBPGNKJ>&UM;6-I9II7"1Q(HRS,QX"@
MDD\ "OC#]J7_ (*.8\#ZE=>&O$$/@;PS\L$?BB\A4W$Q<X5X(Y4=5#<["\;,
MP^;:H(->+GG$&"RFE"IBV[SDHPC%.4YR>T8Q5W)^B,*^(A2BY2Z)OHM%N[NR
M2\VTC[-U'5K71[<S7ES;VL(ZO-((U'XFJVE>+])UV4QV.J:=>2+U6"Y20C\
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M%?>(O^A;\2?^"FX_^(H_X5]XB_Z%OQ)_X*;C_P"(K[RHH_XEQP7_ $&R_P#
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MC4-/:37O#<<\%E=Q7$L+"&< 2PR*C!9HFVJ=D@905! !YI ?._P%_;)^)'Q
MU;3;K5?"]Y+HOB32KC4$EB\*:EI]MX=9;9KB'?>3_NKR.3'E[T$9W%" 5--^
M'7[3'Q4\3:)\.YM:F\&QV_QD\'W6JZ0;&SN%ET.YCT]+I'F+2_OE<."5384;
MY0S ;C[!X#_8Q^'?PTU87FCZ1J4'E6\UI;6\VN7]S9Z?%,"LBVUO+,T5N&4D
M?NE7 X&!Q6SH_P"S?X-T&S\"V]KI<JP_#;3FTGP\K7L[BSMFMEM61MSGSLPH
MJ[I=[<9SN)-/0#F_V$KO7+W]DGP3=>(]4CUC4+G3UG-WLD5WC8DIYC2.[/(%
MQN<M\QR<#.*^?/!'[1\T_P"UC;_$9X?&2Z!XGUR;PBT\NEW2Z"-(^6.QN4N&
M7R"YO4D.5;)%X1_#@_6'@/X%^'/AG\,)O!VBPZE:^'YDGC$$FJW5Q) DV=R1
M2R2-)&HW':J, G\.W HUWX">$_$?P5;X=W6DK_PA[:>FF"QBGEA*0( $"RHP
MD5EV@APP<$9SGF@#S/4OVE_$EIXRN_!4=MIS>,&\;0:-:#RSY?\ 9,D)O3=E
M-V3MM8YD)!"^:H^E<3X'_;=\=^//B=!=:;X6U34O!]UXCET);&V\)ZBTD5M'
M>/:/?-J?_'KE&C:1HMN @9=^]<5]#?\ "D/"Y^,%OX^;2PWBVUTDZ)'J#3R%
MA:&02%"F[86W#[Y7?C(W8)%8%K^R%X L?B,WBB#2;Z'4I-0.KM;QZQ>KIK7O
M_/R;$3?9?.SSO\K.XEL[B31H!Y-X*_:@^)EY<>'/$FJ1^#9/"&N>-I_!WV"V
MMYUU!5^US6\5WYQ<ID-&,Q;.5&=^3M'2:9^U!XAO/AGH>K-#I:WFJ?$=O"3K
MY;;/LHU&6VW ;L^9Y<8.>F<G%>C6?[-_@^P\,Z9H\6F3KI^CZZ?$MI&;^X)C
MO_/>X\TL7W,/,D<[&)3G&W  K$/[%'PW/CK_ (2(:'>KJ2ZNNO1JNLWRVEO?
M!MQN([83>1&[G[Y1!OYW9R:- /)/!O[;OCOQM\4TN--\*ZKJ/A";Q%/H8LK;
MPEJ+216\5T]LU\=2_P"/8D-&7:': %)&_<O/UA7F=O\ L@^ +/XB-XGATF^A
MU![\ZJUO'K%ZNG->$DFY-D)OLWFDDDOY>223UYKTRDP"BBBD 4444 %%%% !
M1110 4444 %%%% !7S#\;O\ DJ^M?]=%_P#0%KZ>KYA^-W_)5]:_ZZ+_ .@+
M7X%](?\ Y$.'_P"OR_\ 2)G=@/C?H<]HO_(<L/\ KZB_]#6OK^OD#1?^0Y8?
M]?47_H:U]?UXGT</X&/]:?Y3+S#>(4445_3!YQ_-_P#\%4_"FI? [_@J)\4G
MC,]G<3:^GB*PG(^;%PD=PLB^PD+@?[E?7?[/?["WP]^)GP \+:IXB\-V=KXE
MURT369[_ $RZF5@UPIDCQN8C:$="4QC<#R17>_\ !QM^PAJ'C[PCI'QP\+6,
MU[?>%8/[.\300KN<Z?EFCNP.I$+DJX&3LEW<",U\^_\ !)_]L:3Q7HMO\,=6
M622^T>UEN-*O=^[S+92&,#9[IN.TCC;QVY^=\:,1GKX5HYOP]5E3EAI)UG"3
MC/V:BU=M-<T8M\SB[Z/F^R[_ (UEV5X'"\3U\%FM-3A7NZ?,DXWDT]+IV>C5
M]-K=3R7]J?\ 9!\1_LG:[:M?7%OK6B:HK26VIVD+K&A#8,<RD8CDY!P"5((P
M>H'D=WJ>^/[WZU^SS>*;&UTJ3^U+BPATUL"<WKHMOC_:W_+^=?CA^TK\4=%^
M(OQN\2ZMX=TC3=#T.XO9$L[:Q0I"\:DJ)=O13)C>0  -V *^D\"O&+'\7X>>
M$Q]#WZ$4Y54THR;>B<;+EDTF_=NM&_=ND?GGB9X<X'):L<5@:ONU'I3=VXI+
M5J5W=7[V>JWU9]3?LP_\%=[?X#_L_P!OX-\1^%;S7)O#Z^3HTUA<1VR20EBQ
MCG+ D%<L0ZJQ;@$#[U?1?[+/[5'_  U=\&Y/%$VFV>CW5O>R65Q9P79G"% K
M!CE05W!L@'/'>OR!U+5<@_-7ZB?\$5?@7_PG_P %='L+>.XC_P"$DU&?5];N
M%D!\BQCD,,>/[AE,31KGGEW'"5\7X^>&.45\!]9RV@UC<57A%2YI-+F4I3;C
MS<L8J*E.346[KMM]IX8<59QB,3# 8FIS4:=-I*ROI91UM=M:)7=K'Z@_LT:3
M=:)\!O"UO>+)'=?85ED23[T9<E]I^F['X5W--@@2VA2.-%CCC4*JJ,*H'  '
M8"G5]5A</##T84*:M&*27HE9'[E"+C%)A117DGQO_:.U#X3>*FL;?1K?4+=8
M(Y6D:<HREBPY !XXZ^]>3Q%Q-E^183Z[F<^2G=1NDY:N[6D4WT9I&+EL>MT5
M\W?\-UZA_P!"Y9_^!;?_ !-'_#=>H?\ 0MV?_@6W_P 37PO_ !&[@_\ Z"7_
M ."ZG_R(_9R/I&BOF[_ANO4/^A;L_P#P+;_XFC_ANO4/^A;L_P#P+;_XFC_B
M-W!__02__!=3_P"1#V<CZ1HKYN_X;KU#_H6[/_P+;_XFC_ANO4/^A;L__ MO
M_B:/^(W<'_\ 02__  74_P#D0]G(^D:*^;O^&Z]0_P"A;L__  +;_P")HH_X
MC=P?_P!!+_\ !=3_ .1#V<CZ1HHHK]8("BBB@#S?]J_XOZY\"O@GJ?B;0='M
M=8NM/*F5;F?RXK:(YW2D#E\':-BD$[NHQ7EVL67QHMOA!/XXUOXN>&_#4=OI
MXU3[#%X=C:TB&P.(Y)I'W\YV\ \D8W5UO_!02Y67]G"YTK<5;Q'JNGZ0N.O[
MZZC!_P#'0:YS]I_]F/QE\2DU'6IO'=DNC^&W74]'T"?3!_9Y,"[P+L[_ -X<
M@X8C ZXK\VXE^MU,;B%052HJ=.#4(5/9J,I.I>4G&4&[**TO*[=DE>Z_3.&5
M@Z>"P[K^RINI5FI3G3]HY1BJ=HQ4HSBFW-ZVC9*[;V?K?[.GCW5_BC\#O#'B
M'7M/72]6U:Q2XN+=00H)SAP#RJNN'"GD!P#R*\B_:+_:IUCPY\9]'TKPS)&N
M@>%-5L(_&%XP4K_IDOE16JY&=P4M(Q'3Y!GJ*T]5_;)FTG]DKPOXO;2L^,/&
M=JEMHVC0H7-W?/E5V)]XQ9P_J5*CJ17E2?#/XAZ]^R1JG@FS^%FJ1ZCK;-J>
MI:WJFL6L-S<Z@765[A85W.SDHJJ&VX 4=JYLZSZK4P5/!9=4G.HJ2J.<82<I
M-13IQ?)%\CJ2M*5[)133MS)G3D?#]&GC:N-S&E"%-U94XPE."C%.3522YY+G
M5*-XQM=N;35^5H^KOC%\4M/^"GPQUKQ5JBR-8Z);-<R)']^3' 4>Y) _&O*;
M+1?V@/B3I_\ ;#>)/"'P_6X3SK71DTLZG*BD95+B9V #=,F,$#L.U:/[-/B>
M^_:L_9OGN/&O]AZA9^(%DM)+2QBDC:!%&QXYMS$^:&!/&,9%<?XA\"?%+]C[
MP+=:EX:\9:5XL\%^&[4S'2?$B>3=6UM&O^JBN5X;:O"AMHX4<]#Z698^>+IT
MLRM5>$E#F_=RY91>_-)1:FX\MK*$G;7FB[JWFY9E]/"5*N6WI+&1J<O[V//"
M2T7+!RBX1ES7NYQ2>G+)6=_4(=!\>?%3]FZ'3]4U:/P'XXU&W$=U?:?#]H^Q
ML)>6C4L,%XU_O?(7."<"O0-"TZ32-#L[2:ZFOIK6!(7N9L>9<,J@%VQQN8C)
MQW-?/OQM^)$OQ'?]G_4H&O-)T_Q1XCM-0FM7<JQQ 98XWQC.&['@G!Q4O_!0
M+]H&S\'_  >\2>$M,\W4/$&KZ5(ETEOAETFSDQ$\]P?X%8,54'EB>. 2.G^W
ML'@J&(QDW*7L80CS2D[U/<YXVCLI2YM6HW?72*MRKA_&XVOA\%!1C[><Y<L8
MJU/W^25Y;N,>71.5ETUD[_0]%?&?CN3Q5JGP2C^)VDZ[X@\/>%O!$EC'X:TF
M&1K=+[3898XIKR[08+^;'N9$/"H!D98UZ/\ M7_MD:?X2\"S:/X+O(M:\3ZS
M%%"EQ8N)H-&CN&6-+F9U.%)+C8O5FQVS5QXVPL*-6OBHNFH1C.-VFZD9<R3B
MMW=Q=KZVM)VOI$N!\7.M2H822J2G*4)632IRCRMJ;V5E-7L[<R<5>VOM^A>.
MM%\4:QJ6GZ;JEC?7VC2"&^@@F61[1R,A7 /RGKP?0UK5XSX.^"G@+]CNP7Q0
MUXNCQVNC0Z/>2NW&HR"9I!*R@;Y;B221@,99LJH' %>F:_X\T_P_X;U+4I)-
MW]EV#ZC-;#BX6)4+\H>02!CD#FO=P&.JND_[0Y85%JXQE>T7>SZ/9/IJT['@
MYA@*7ME_9_-.D]%*4;7DK775;M/?1-7+B^)=.;Q$VD"^LSJJP?:C9B9?/$6[
M;YA3.=NX@9QC-6KN[BT^TEN+B2.&"%#)))(P5(U R6)/  '.37SO^S?\%]*N
M/#'A;XR>)M0%KXNO([C7=5U#S1'!)%=0E1;N6Z01(4V#(P4![FLK5O'-M^VM
M\=X?"MW9W%O\+_#VG_\ "0W!N=T"^)SO,=NS*2"+4,)'7.-YB#8P5->-'B>J
ML-"=6FE5K->RAS:N,DFI3=O=4;OGT:5K+F;2?MRX6I2Q,X4JC=*BG[6?+I&4
M6TXP5USN32Y-4W>[Y4FU]/Q2K-&KHRNC@,K*<A@>XIU?)/[,GP)U#X@>!M8N
M_"WQ \7>#O 4WB#4%TK2].6,(UHLQ56AED5GC1R&X'?)&"<UPOP1AU[XK_"/
M7/!?@_7M:TFQL[[5M?U[58+IS>(S32+9V239W&240^=(V<[6'.6->?'C>LHT
M7/".]6,G"TXOG<>7X.KBU+FYI*+44Y<MKGHO@6@Y5E'%JU&48SO"2Y%+F^/H
MI)QY>6+DG)J/-=J_WA17Q/XA^)/C#]HSX%6WB'P[XDUBQM?AGX7LM2OIK&9X
MWUO6_*22:&4KC='"B-O7H6G'7!Q]B^#/%%KXV\(Z7K%C-'<6>J6L=U#(ARKJ
MZA@?UKW,CXEHYG4E&C%J/+&49-JTTVTVDM?=DG%]]&M&CP<]X9K973C*M-.7
M-*,HI.\&DFDWM[T6I+MJGJFEIT445](?,A1110 4444 %%%% !1110!X_P#%
MC]FN^D\9S>-_AUJT?A7QK( +M)$+Z;KRCHEU&/XO21?F'OVJ^#_VQ;31_$-O
MX:^)FER?#WQ-)\D3W<@;2M2(ZM;W/W2#UVM@KG'/4^TO(L:[F8*HZDFN#^,G
MC_X;P>%;JQ\<:MX5;2IAMFMM2GB96]/D8YR.Q R#TKY?'9>L%*6,P-:-&^LH
MR_A2?5M73C)]91:N]91DSZK YB\=&.#QU&5:RM&4/XL5T2=FIQ72,D[+2,HG
M>(ZR(&4AE89!!X(KG/BQ\/?#OQ+\#WVG>*-)M]8TKRVDDAE3<R[1G<AX*L,<
M%2#[UXK^Q-=I#XV\46/@R37KKX1V\,3Z1)JD3I';W99O-BLS)\[6^W#<@88X
M'')^CB,BNS+,;3S; >TJ07++FBT[2B[-IM.R4H.UT[*ZZ+8X<TP-3*,P]G3F
M^:/+)-7A)72:35VX35[-7=GU>Y^2N@?M ?$SQ!JVEV.B^*O&$UPK"VTJR@O7
MEE5?X(P!]\A0!E@>!DU]N?LY?M,^--"UK2O!_P 8=#N-#U;5OW>D:U(BQVVJ
M2 9\B0J=BSX!( P&QC /7@_V8O@3:_LP_MXZUI&I1JMEK6EW,OA2ZE'RRH9H
MW>%2?^6J1G:>Y52?XJ]0\=?%W0O%OQ!\0_"?XMZ78:%9ZRWG^&[V2Z*V>N6R
MA6!28[?+O(I 24X(PI4L.3^5^'W#.<4*-7&2Q4O;PFX.E)W@^6VDKW:YE9QE
M'X8M-*2=G^L^(?$V35ZU+!1PD70G!356*M-<U]8VLGRNZE&7Q233<6KK4/[0
M&L?"W]I#_A#?'BZ='HOC*?=X,UBVC:*-W"@-IUP&)Q< _,C XD#8 4C;7LU?
M '_!8']H'PGJ_P -_#WP]T/4K75];L]0BU">:WN!.^FQQ1NJ;I 3B1RP.,[O
MER>U?5?[%'QBN_CQ^S!X1\2Z@V[4KNT\F\;_ )Z31,8W;_@17/XU^XV=KL_"
MM+V1ZI1112 **** "BBB@ HHHH **** "BBB@ HHHH ^?/%O[27BS0+'XE:!
M'_8O_"9Z3XHL-#\--);/]E>'4Q;_ &.6= ^YQ$9)_,*E=PMGP!3= _;$N-3M
M_AU?7TFFZ5IMYX:U+Q%XODDB9S8BS,-NT<>&^4FZE8 88D1%1R:Z;QQ^S1<^
M*_VL?#/CZ/4+6'1]+LMNHV!4^9>W4/G"TESTQ&+JXZ\\KCO7&W7[ 8\3:;\8
M=,U;6H8]-^(,:V>C?9H-SZ-;">:](=6P')O+F5BHX**@R#TK0#M;?]M+PC#H
M^L76K67BKPW<:/:QWIL-8T::SO;R&29($>")AF3,TD<>!R&D0,!N%<[\2_VW
M&\/Z1X6N-*\(^,(KC5O%EIH%_::IH4]O<6T<J[V9%. [,N A4LI.[/*XKC?A
M9_P3YO/!>B^*G;PU\"]%U/5]*;28(M(\+2M9WT;312RB\$LFXQR>2B^6F-I^
M8,2JBH_!7["'C7P1\/(+?3M8\(Z7?:;XITSQ!I>@6QOY/#^F):AUDCB\V1I4
M,HD+$)M0,B_+R31H(]N^*GQ4U3P=\9_ACH-FMK]@\77M]!?^;$6E58;-YDV$
M, IWJ,Y!XXXZUI_%CXVV?PEFL()=#\6:_>:BLDD5OH>CRW[HD>T,SE1L09=0
M-S MDX!P<<O^TC\)O&GCCQ3X#\1>"KKPM!K/@V\NK@Q:XMPUK,)[9H"!Y.&R
M-Q(Y XKSSXP?LT?%_P".RZ!=>(]6^'-RVGBZMKS15;58]&E61X6BN]D<J/+/
M&$D79*3'A^-I+$@RQK?[;MQXQ^,W@C3_  BM[#X/U30[CQ'J>I2^&;F_EGAB
ME2)K=%21&@96,BNY60K)Y:>6=V1V!_;E\(V%OJSZMI7C3P])I%I%J$L.JZ'+
M:R2VDEQ';FYC#?>C1Y4+GJBG)%<%\,_V%_%WP_\  6E:3;^+M/TN_P!)\$:M
MX5M]1TR&2)X)[K4([F&>->-BJB;2H;*G&TG&:P/ /[(5Y\ ?$/B;QSXZ7PLW
MA_4/"EWH6LV'ARSU+4+N\$TT;><S3---.S#>&&!@G/.6-&@'OGCS]J+PO\/O
M$FK:/<+J]_JFDI9;[73K%[N:YFN_.,-O$J9+S%())"H^[& Y(7FN)\=?MP6^
MG7/@J/1?#OB*XFU[Q.N@:O9W6DRQWNCYA\W$D605=E:-T)RK1[V&=M>:^%OV
M$M4^+O[)VCCQ$UG=^,KO7%\3S6WB>Q-Q:7J) +.VM+R%2& %C' #M.4E!89Z
M5TW@O]B'7OAYX T/_A'[/X7^'?$&E^++?Q%)8Z/I5Q::0\<<#VYCSO,KR;)&
M8.V!NPNW:.30#>^$O[=UOXN^&UOJNK^%_%0UO4-8U.QL]'TW19I[R>WM+EHS
M-Y>20J*8ED=B%65B@YP*]F^''Q$TOXK>#;/7M&EFEL;PR(!-"T,T,D;M'+%)
M&X#)(DB.C*P!#*1VKY7\;?\ !.+6_%MO#)?0?#/Q1-H.KZRVE6/B'3[BYL;K
M3]0O3>9G"L&CNXI&95>/*,C$$9.1[-\"OAYKWP%A\'^"[+2?"L/AY;#4+S6)
M='TV6QM;2Z,\;0Q6Z%V 4B64'<2S>5N.,XHT Y_]J?\ :2\3?"#7O&%KHJZ2
M5T/X=7WBBT-W;M)_IL,PCCWD.,Q8/*C!]Q3=+_:WU3Q)X,\$S1V5GI?B.?QC
M;>$_%6F3J9&TZ8QNTJH0PX8!)(W.04<'!K0_:4_9>UCXU:[XJNM/U+3+-->\
M!7GA.%;@.3%<33"196V@_NP!@XYSVIOQ:_9#F\8_'+P/XWT/5+?2;C2;VUD\
M1VK(?*UV*V63[._ _P!=$TCA6/5)&4G 7!H!UG[2GQQ;X+^")/[+M8M4\6:G
M!<?V-IS/M65HHC))-*1RL$2@,[]MRJ/F=0?/?B)\6O']G^S)X<^)EGXS\*^'
M;.7PU8W]_97'A.;4Y;^^N$BV1P%;Z'9YDLJ1HA#'<Z_-7;_'K]E+P[\<9[S5
M;AM6M/$C:/-I%M=V>M7M@HC?+".5;>1!)'YFUBK @[1D' KGM#_9*NM&^%/P
M;\(?VC#-I?@'4K;5-;6>XGN&U&6"WF9%B,A)V"]>*14;"HD850-J@&@'/Q?%
MGXO:AKMEX1DUCX=^'_%'A_PC!XG\17FH:9/+:74LTLRBWA1;E###'Y+"2<M)
M@D83M6#:?M@_$3XV>#-:\8> (?"NDZ)X.\,66NWVG:M9S7EQK-S/:F[DM(YH
MY8U@5(@JK(4D+,_*@"NW_:P_9:UOXZ^.O#^K:?!\.-6M])B,:6_BW0?[0_LJ
M??N%Y:LI#&3H#%(?+;8IX.<\YJW[%?C/P)I.K>'?AWXF\/V?AGQ=X>L] UN7
M6K6:?4+9H+=[5[RV,;*C2R0LI*R<!T!S@[0: 8_CC]O;4]4^(5U#X7UKP?I>
MGZ*VGHVGZOIUW/)JS74$-Q^]O(F$.FQ[)D2.297$D@8':!7UE$YDB5B-I8 D
M9SBOG+QM^QOXGC/BKPYX1USPWI_@/XAVT%KKL5_8RRZC8K':1V;M:NC!&+P1
M(,2#",,C.<5]$V%DFFV$-O'N\NWC6-<G)P!@?RI,":BBBD 4444 %%%% !11
M10 5\P_&[_DJ^M?]=%_] 6OIZOF'XW?\E7UK_KHO_H"U^!?2'_Y$.'_Z_+_T
MB9W8#XWZ'/:+_P ARP_Z^HO_ $-:^OZ^0-%_Y#EA_P!?47_H:U]?UXGT</X&
M/]:?Y3+S#>(444'I7],'G$5]90ZG936US#%<6]PC12Q2H'21&&"K \$$$@@]
M:_+S]H__ ((BZO\ L\?M#V'Q@_9ZAAOK"SNI+C4O L\X@80R*4F2PF8[=I5V
M*Q28",J[6(P@_3J_M+V9?W%PD9]UKF=:\->*KG=]EU:&/TXZ54K5*%7"55S4
MZL90G%[2C)--/U3>JLUT9YN993A\:HNJO>@U*,EO%K5-?Y.Z?8_ /_@IU\>/
MB/J/C:?POXJ\.ZSX/\(Z/.)[2#4--FLVO3T6>5Y!AF&_9M1B@(.,YR?E?1M;
M;Q5JL.GZ4LFJ:A<L%AM;)3<3S'T5$RS'V K^GC5OA[\3)PWV?Q);JOH<D5DI
M\+/BU%)\GBBSC7/(1-N?RKU.%\9@\@RRGE674%&G35E9VN^LI::RD]6^I^?9
MMX:O,<7+%XG%-N3ZQV71+WMETT/QI_8X_P""&?QL_:IUNSNO$NEW7PP\'L0]
MQJ&M6Y2^DCR,B"T.'+D=#)L48SD\ _N'^RE^RAX-_8T^#FF^"?!-A):Z;8J#
M+<3OYMWJ$O\ %--)@;G8^@"J.%"J !CZ3\//B9"X-SXDMY.F>376:+X9\5VV
MW[5JT,GKP>:,RS>OC7^\=EV6Q]7P[PE@,HC?#J\WO)[^B[+^FV=K15#3[2^A
M7]_<+(?85?'3FO)/J KYT_:94/\ %.16&5-C""#WY>OHNOG7]I?_ )*M)_UY
M0_S>OQ'Q^_Y)B/\ U]A^4CLP/\3Y'BOB+PZ=+<S0_-;L>1_SS/\ A67FN^=1
M(NU@&5B 0>X/6OHZ#]FSP.\",?#MGDJ">7_QK^:>!_#O'\4NM]1J0A[+EOSN
M2OS<UK6B_P"5W-L5%4VFNI\9T5]G?\,U>!O^A=L_S?\ QH_X9J\#?]"[9_F_
M^-?H'_$NV??]!%'[Y_\ R!R^U1\8T5]G?\,U>!O^A=L_S?\ QH_X9J\#?]"[
M9_F_^-'_ !+MGW_011^^?_R >U1\8T5]G?\ #-7@;_H7;/\ -_\ &BC_ (EV
MS[_H(H_?/_Y /:H[JBBBO[$.<**** .'^./P0M?CC8>'K>\OKJQC\/ZY;:VO
MD 'SVAW8C;/8[NO; KS_ %;]ESQQ\5-=NK?X@?$JXUCP;+<M-_8.F:?'I\=S
M'N)2&:5!YK1@8!7<=V.3GFO>**\3&\/8'%U75K1=Y6YDI22DDK)3BFE)+M)-
M;Z:GN8'B+'82DJ5"2M&_*W&+<&W=N$FFXOSBT]K/0X.3]G;P[/\ %S1_&$D<
MTEUX=TW^S-)LB1]CTY><R1Q@<.5.W/8 8KO***]+#X.AA^;V,5'F=W;J[)7?
MR27HDMCS<3C*^(Y?;R<N565^BNW9?-M^K;W/*;S]E]=!7QI-X-\3:SX/OO&5
MS!?.UL(YK>RN(V)DDBB<%09LX?L<#&*P[+]C:Z\9ZI:W7Q,\>>(/B%#9NLL>
MF31Q:?IK.O*M)!;A5DP><-P>AR,@^Y45Y53AG+JC2G3]U?9YI<CNW+6%^1ZM
MO6+^ZQZU/BC,Z:?)47,[>_RQ]HK145:IR\ZT26DEMWN<5\:_@/HOQS\%V^CZ
MDUY8?V?<1WFGW=A+Y%QI\T?W'C8=,#C'3'N 1G?#_P#96\%^ ? 6I^'_ .RU
MUBWUYA)K%QJK?:[C5W!R#.[<L!V7[HYP.3GT:BNRIDV!GB7BYTHNHURW:3=K
M6M]SMZ:;''3SK'T\,L'"M)4T^:R;2O>]_O2?KKOJ5=0T*QU;19M-NK.UN-/G
MB,$EM)$&A>,C!0J1@KCC'2N'F_96\ K\+=4\&V?AO3])T'6,-<Q6"?9Y&=6#
M))O7YMZ,%*DDXP!TXKT*BML1E^%KZUZ<9:..J3]UZ-:]&MULSGP^8XK#Z4*D
MHZJ6C:]Z.J>G5/9[H\O\ ?LF>&_!?B:UUR_OO$?B[6M/_P"/*\\0:G)?-8=1
MF)&PBM@_?V[AS@C)KHK+X&^&[/XH:[XP-DUQK7B*QCTV\>>0R1-;H /+$9^4
M!L+NX.=H]ZZZBL*&2X"C!0ITHI1?,M/M6:YKO5NS:N];:'17SO'UIRG4K2;E
M'E>K^&Z?+9:)72=EI?4\5\+_ +!O@OPZ]G;W%YXJUK0=+D\RPT'4]8EN-+LR
M&W*!"3APO82%AZY/-=!\4_V2_!?QC\6V^L:U:ZC]HAM/L$L=GJ$UI#>6X;<L
M4JQLNY0<X&1U.<\8]*HKFCPUE4:+PZP\.1M-IQ33MMOT6R6R6BT.F?$^;2K+
M$O$3YTFD^9IJ^^W5[M[MZO4J:)H-CX:T6VTW3[2WL=/LXA#!;P1B..% ,!54
M<  >E<U\&O@7X<^ _ABZTGP[:20VM]>2WURTS^9)/+(>2Q/8 !0.@"CW)["B
MO3>#H.I"JX+F@FHNVR=KI=KV6W8\Q8S$*G.DIOEFTY*[]YJ]F^]KO?N<W\.?
M@_X:^$O@O_A'?#^D6VGZ*S2.UJ"TJN9"2^XN6+9SC!)XP.@ KS&T_8]U7X>3
MS1?#KXD>)O!.CSR-(-)%O;:E9VQ8EB(5N4?RUR>@KW*BN+$9%@:L*<'3Y?9J
MT>1N#BNT7!Q:3LKI.SLM-#NPV?X^C.I-5.;VCO)32FI/O)34DVKNS:NKO74\
M5_X4)\6/^B[:W_X3.D__ !BC_A0GQ8_Z+MK?_A,Z3_\ &*]JHK#_ %=PO\]7
M_P 'UO\ Y8=7^M&,_DH_^$]#_P"5GBO_  H3XL?]%VUO_P )G2?_ (Q1_P *
M$^+'_1=M;_\ "9TG_P",5[511_J[A?YZO_@^M_\ + _UHQG\E'_PGH?_ "L\
M5_X4)\6/^B[:W_X3.D__ !B@_ /XKL,?\+VUSG_J6=*'_M"O:J*7^KN%_GJ_
M^#ZW_P L#_6C&?R4?_">A_\ *SQ%?V>OBGN&?CMX@V]\>'M,_P#C-2W/[.'Q
M$O$"R?'+Q;M4Y^31].C/YK"#7M-%+_5O!VLY5/\ P=6_^3#_ %HQM[J-+_P1
M1_\ E9XC<?LG^++YR;CXV?$5LILQ#]F@XY_N1CGGKUZ<\"B#]B^:5-M]\5?B
MS>)QE?[?:,''T6O;J*C_ %5RR]Y0<O6<W^<F/_6S,TK1FH^D*<?RBCQ"#_@G
M[X#N-W]K77C3Q &ZB_\ $MY@_P#?MTKJ/ _[(7PQ^'4R3:3X)T".YC^[<W%O
M]JN!_P!M9=S_ *UZ/16V'X9RFA)5*6&IJ2Z\D;_>U?\ $QQ'%&<5XNG5Q51Q
M?3GE;[D[?@-AA6WB6.-5C11A548 'L*=117N'A')_&3X-Z3\;/"JZ;J37%K<
M6LRW>GZA:2>7=Z;<+]R:)^S#TZ$$@@@U0^.?[.?A?]H_X8/X5\86;:K:85HK
MHD1W5M.OW9XW4#9)GDX&U@2K*48J>[HK"&%I0K2KQC:4DDWWM>U_2[.B>*JS
MHQP\I7A%MI=F[7MZV1^;OB'_ ((A^*H/%C1:-XTT&309),B>[M9%NXDSW1<H
MS8[[E!-?>GP(^#FF_ #X2:'X0TEI);/1;<0B63[\[DEGD/NS$G';.*ZZBNER
M;.>P4445(!1110 4444 %%%% !1110 4444 %%%% $4M]##<QPO-$LTV=B,X
M#/CK@=3BDEU"W@NHX'FA2:492-G 9_H.IKX8_:M\/7/B;XC?%_Q=:Z39WNE^
M#KO34NO%4]Z8=:\%FVM[>>Y&EP8*R@1.LHW20[I)9%(E4**U/CKX*T7QIX0_
M:.\<:Q#')XT\$ZPD7A[4GD*W6CQ0:?8W%JD!SF-7FED)V@;S(P.[  KE ^TY
M;^""YCADFA2:;.Q&<!GQZ#J:FS7Q3\<O!>E^-?#W[0_C;6K*-O&W@>YA7P[>
M-,RW&DB&PMI[<0'.8P\\D@.W&_)!W=*]Q_;3U28?L=>(M]U>6-[JEK:6$;6O
MRM+<7-Q# D+'<NV.6218W8$%4D8CD"E8#V"SOH=0@\RWFBGCR1OC<,N1UY%*
MUY"B2,TL86'_ %A+#$?&>?3CGFOC'P7XOUK]DB_^(UG:^ UT7Q!J%MI#Z9X6
M\(6MWK^DZ>LQN(3JCK#$LWWXW,R+"F5@B +,Y>L?X6M'X[_9K^-O@VPU+6K.
M^USQ5%;RZGXTMKG0QJ#7PM8GC:2:-=L\C+*H@52R"6$;,.F7R@?<5CJUKJ@;
M[+<V]QY>-WE2!]N?7%333I;1[I'6-<@;F.!DG _6OG_]D#P^OPD^)_C#P/=^
M$? 'A_6(;*SUB6\\(6DEK9WD$KSQQQRQR$LLJ&-_XB&5\@+TKRK]OOXW7/B+
MQ!J&C7VC_$33]!\$:UH\MJ;7PKJ,EEKUV;VUD>5KI8C"\,4;,D<8;,D[=RJ*
M58#[1GU"WM9XXI)X8Y9CB-&<!G^@[_A4DLR0)ND947(&6.!D\"OEW]JKX0>"
M?BCX@U*UTO1KOQ!\7?'&G0-I4MS),LW@R$*4BU ]&L8HG#R;0%>>5&09.[;P
MO[9?QNO=2\66>CZMIGQ+AT3X?Z_H_D26WA+47@\37BW,#2W+3I"8I(D3<L4*
M,3+,Y/.U%)8#[9N+Z&TDC26:*-YFVQJ[A3(?0>I^E2U\/?M#>&]6^+OQ<^+6
MMWF@^%]6TGX>VEC<Q_VY>75IJ%G9_8OM)&G^7M-G<,_F-]I<'+*J;<1G'V=X
M*U:/7_!NDWT*W"PWME#.@G.90K(K#>?[W//O0!@_!+XFS_%;POJ&H7%K%9M9
M:SJ&EJD;%@RVUS)"'Y[L$R1VS737>OV.GS^5<7MI#)C.R295;\B:\S_8\_Y)
MQKW_ &-NN?\ IQGK@?VY/@3X-^)^O^&]%?POX?N?&GQ&OUTEM8FL4EO+'3X8
MVENIXV(R'2)=B'HK2J:\[**TZV#I5*CNW%-OY'JYYAZ=#,*U&DK1C)I+LKGT
M<^J6T44+M<0*EP0(F,@ E)Z;3WS[4V^UFSTME%U=6UN6&5$LJIGZ9-?&'Q[^
M$%UXW^-7BSPKI7AOP7?>'OAOX/TK^S;/Q!=7$<.FV96Z#"Q6(@PSMY"K]K8G
MRA!& K9;!X\^'UQ^T)<:7XSL=+^&'BG1]"\ Z7=#1_&=U+?:E:1R)+<2;PF/
M+>5%0"XDR&V,=I&:]*QY1]KHXD0,I#*PR".A%(L\;RM&KJTD8!90>5STR/?!
MKS+4OCJGAG]D^V\>:+X5UO5 =#@O=/T#3;.2YNW,D:>5 L<2LV 64%E4X4%L
M<8KY*\)_%_5?#>F_M.ZI:7'C.;Q5/X7T[4IM0OM"O=)\F9;>=9C$MQ&IMD42
M9A1^2D9<;MK-2L!^@%M>PWAD\F:.7RF*/L8-L8=0<=#[4EI?PWZLT$T4RHQ5
MC&X;:1U!QWKX^^$7@#2O@O\ $[6- \46OA;P'I_BWP-=ZFVI^%]>N+2WM[.&
M>UBD>\>9MKW:FZ4K?*5+ RY X-=5^SOX!L_@7^U[J^A6GA_3/">D:]H#2:+:
M:-=FYMM5AMK@*U[=[@I2Z831@85@5+9D<X + ?34TRV\322,L<: LS,<!0.I
M)J&_U>TTK;]JNK>V\S.WS9 F[&,XR>V1^=?'?_!3[XPWFL>"_''@EM)\>V.@
MZ5X<DOIM2L?#M]+8ZM>,A:"!KR.(PQVT6 \Q9P"=J$@!P>@_:$^%.H?M7?&3
M0]4TG3_AOK-IH?A4RQ:%XYM;E;RQ>\N59Y9+(!98=Z6B1J\@&"LGRMM(IV ^
MI)=5M8(X6DN+=%N"!$6D $A/3;Z_A3;S7;'3IO+N+RUMY,9VR2JK8^A-?)OB
MNR^&/QP^$7@O7Y/!3:YXN\9>%[>U\*^$#<M*FD1[?]=$JX2WAC9EW7FU?E6,
M Y94-S]H[]FW0[KX3?#?P?K&DZ!XJ^*7B:#3_!__  DM]8+<74<<%N7OK\;^
M=R0Q3NN3_K)(\]32L!]703I<PK)&ZR1N,JRG*L/8TZLKP-X*TWX<>#=+T#1[
M=;32]'MH[2UA!SY<:*%49[\#KWK5I %%%% !7R]\:',GQ5UO/:<#\E6OJ&OD
M_P#:!UR/1OB7KA.UIGG^1,]?E7GZ5_/_ -(B5LCPW_7Y?^D3.W R2FV^QS>I
M^)%\-R0S*JR7$<BR1QGH2I!Y]N*[ _MN^*/^@;HO_?,G_P 57CMQ<O=SM)(V
MZ1SDFF[J_EW).+,WR=3CE=>5)3MS6MK:]MT]KLNM451W9[)_PVYXH_Z!NB_]
M\R?_ !5'_#;GBC_H&Z+_ -\R?_%5XWNHW5[G_$4N*_\ H.G_ .2_Y&/+$]JT
MS]LGQCK>HP6=GH^DW-U=.(XHD20M(QZ ?-6EXB_:8^(WA+4_L>I>%[&UN?*:
MX"&.1MT:C+,"K$$*.3@\=Z\0\->([GPCXBL=4LFC^U:?,L\0<95B.Q]CT/UK
MT#PE\3?#]]X[74-<OO$=K##J/]JQE9!.LKYWB)P02NTDINCVATX*@\U]3D7B
M!FV,I>RQ6:5*=9S23;@H*#6K=X[[[RBDDOB;2)<5T1VWA/\ :6\:>,?#^JZI
M;Q^#[6TT5!)>&Z-TK1(<X?"(^X'!Z$GCD#C.A'\:?B5-XUL]!BTGPM/=ZA:?
M;K::.:5K::#!(</UP<8Y4<D=N:X3P'XDTF'PU\3)+6;2K*'5@JZ79WUS"AF^
M=R$\MF!*_,,\8P<9X-:GC_XOZ5H'BW0M2T^;^T-<^S6B7XTW4(UL[;RB3Y$;
M,K($=F^8 @ (.1DFOL,'Q5C5EU+%X[-)JS3FXM>\O:U(/E7*VW*,8-)*Z4G-
M^[H3;6UC6TC]IKQIJ6D07UQ#X1T>WNKQM/@;4'N(_-G7[R?(KA=O0E]HSQFD
MU']I;QUI?AR_U62Q\*M::;J+:9*$FD:4R@X)5<\IGOP>^,9(BUOQM9^'OB'?
MVMG=^#_$'@G7KA;RZM;G4;?-I)(/WK)\V0006P V<X&"<UPWB<>'6^$>M?V;
M-I;W"^)7:RW2QB^>RY"G!/F%<GN,XYK#,N),YPM&I"&93E.G&I>[46Y06DH^
M[*,X2WCR\K6D9:^\Q)=CH?\ AMSQ1_T#=%_[YD_^*H_X;<\4?] W1?\ OF3_
M .*KQO=1NK\M_P"(I<5_]!T__)?\C3EB>R?\-N>*/^@;HO\ WS)_\57-:[\7
MKCXG^)VO-2AMK6Z>)8D$.1&P7)[DG/)K@-U&:\K..-L]S6A]5S'$RJ0NG9VM
M=;/1+N:4Y*$N9'?2-M7/H0?UK[$TV0S:=;L>K1J3^0KX@\/^)/ML8M[AAYPX
M5L_ZS_Z_\Z^W='_Y!-K_ -<4_D*_=?HWR_>9@O*E_P"Y"L;-246O/]"Q1117
M]3'GA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 >?^-OV6/A]\1_'<?B;6_"
M^GZAK*&)GFD+A+DQ',1FC#".8I@;3(K8P,=*/&_[+'P^^(_Q!M_%6N>%]/U#
M7K?R2+EV<"4PMNB,L88)*4/*F16V]L5Z!11<#S_QQ^RS\/OB3X_M_%&N>%]/
MU'7+?R2+F0N!+Y+;HO-0,$EV-ROF*VWMBMK6O@]X:\2)XD34M)@U"'Q=%'!J
MT-R[S0W:(FQ!Y;$JN%_N@9.#U&:Z:B@#D?A/\"?"?P/L[R'POH\.F?V@ZR74
MIEDGGN2HPN^61F=@HX4%L*. !4U[\%?"NI:#XBTNYT.RN=/\67+W>KV\RF2.
M]F940NP).&VQI@C&"H(P>:ZBB@#@O#'[,7@;P;X(U;P[INAK:Z7KQ!U$"[G:
MXO", ;YRYF. ,#Y^!P,9KI?&7@'1_B#X=&DZS8QW^G":"X\F1F \R"5)8FR"
M#\LB(W7JO.:V** /+O&_[&'PV^(GC/4_$.K>'YIM9UHQF^NHM4O+=KGRT$:;
MA'*H.U0 ..!7:^(/AQHOBKPW9Z/J-BEWIVGS6\\$,CO^[DMW5X6SG)*LBGDG
M)'.:W** .$^(W[,O@/XM^*[77/$7ANQU/5+.-85G=G3S8U;>L<JJP65 Q)"2
M!E!)XKNU&T8' '  [444 <7\"OAI>?"OPKJ6GWEQ;W4E[K>HZHC0@A52YNI)
ME4Y_B"N >V16YJW@+1]=\8:/K]W8Q3ZQH$=Q%I]RQ.ZU6<()0HSCY@B@Y!Z5
ML45CA\/"A2C1I[15EZ'1B\54Q-:5>K\4G=^K.(^*W[.'@CXWZC8W?BGP_:ZM
M=:>C0PRL\D;&)B&:)RC+YD1*@F-]R$C.*K?$7]EGX?\ Q8UFSU#Q!X7L+ZZL
M(%M(F#/"K0*<K#(L;*LD0).$<,HR>.37H%%;'.9%MX$TJS\7_P!NPVOEZF+!
M=,#K*XC6W5RZH(\[!AB?F"[L<9QQ4-G\,M!L?$FOZO'I=M_:'BF*&#5I7!<7
MT<*,D:NK$K@*[# '(8YS6[10!P/PZ_9=^'_PGM-5M]!\+Z;9PZW +6]1]UPL
MT ! @Q(6VP@,<1+A!GA:3X>_LM^ OA5::K#H'AVWT\:U;?8[N03S23/!@CR5
MD=R\<8R<(A50>0 :[^BBX'/:Y\*?#_B;X8S^#=0T];SPU=6']F364LKL);?9
MLV,^[>?EXSNS[UC_ !9_9L\#_'+4+.[\4^'[?5+JQB>WBF\V6"0PN06B<QLI
MDC)&2CY4\\<G/<T4 >8^./V./AO\1/$RZQJGAM6U);*+3EEM;^YL]MM%GRX0
ML,B*$7.0H&*Z;3O@OX9TN;PG+#I:^=X'MGM-#DDFDDDL(GB6%P&9B6)C4*2Y
M8\=<Y-=110 4444 %%%% !6#JWPM\-Z]J$EW>Z%I5U=3'+RRVR.[_4D5O45S
M8K!X?$Q4,33C-+6TDFK_ # YG_A2WA'_ *%G0_\ P#3_  H_X4MX1_Z%G0__
M  #3_"NFHKA_U?RO_H&I_P#@$?\ (=V<S_PI;PC_ -"SH?\ X!I_A1_PI;PC
M_P!"SH?_ (!I_A7344?ZOY7_ - U/_P"/^079S/_  I;PC_T+.A_^ :?X4?\
M*6\(_P#0LZ'_ . :?X5TU%'^K^5_] U/_P  C_D%V<S_ ,*6\(_]"SH?_@&G
M^%'_  I;PC_T+.A_^ :?X5TU%'^K^5_] U/_ , C_D%V<S_PI;PC_P!"SH?_
M (!I_A1_PI;PC_T+.A_^ :?X5TU%'^K^5_\ 0-3_ / (_P"079S/_"EO"/\
MT+.A_P#@&G^%'_"EO"/_ $+.A_\ @&G^%=-11_J_E?\ T#4__ (_Y!=G,_\
M"EO"/_0LZ'_X!I_A1_PI;PC_ -"SH?\ X!I_A7344?ZOY7_T#4__  "/^079
MS(^"_A$'(\-Z("#D$6:<?I72H@C154;548 '84M%=>%R_"X6_P!6I1A??EBE
3>W>R0@HHHKL **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
